Sentence examples for response to impeding from inspiring English sources

PIDs were also recorded in humans with traumatic brain injury and intracerebral hemorrhage, albeit with a lower frequency than those in ischemic stroke patients [ 97], suggesting that these electrophysiological abnormalities are common in response to impeding functional and structural damage.

We tested the hypothesis that activation of Nrf2 and induction of antioxidant enzymes in response to arsenic exposure impedes glucose-triggered ROS signaling and thus GSIS.

SAgAs were designed to impede immune response to autoantigen epitopes and are composed of a hyaluronan backbone with peptides PLP139-151 (proteinipid protein) and LABL, a disease-causing proteolipid peptide epitope and an intracellular cell-adhesion molecule-1 ligand, respectively.

These low frequency compound sub clones did not seem to impede the molecular response (MR5) attained after 3 years of treatment.

Autophagosomes induced by CoV PLP2-TM/PLpro-TMs may provide a platform for viral targeting Beclin1 to sequester STING and possibly other critical innate signaling components to impede downstream antiviral responses, thereby promoting viral replication.

Formalisation is postulated to impede innovation and timely responses to changing market needs, which are at the core of market orientation (Kohli and Jaworski 1990; Jaworski and Kohli 1993).

The variation in a population can therefore increase or impede response to selection, depending on whether or not it is correlated to the change under selection [1].

Variation within a population is a key feature in evolution, because it can increase or impede response to selection, depending on whether or not the intrapopulational variance is correlated to the change under selection.

So, while viral infections may impair antibacterial interferon-γ responses [15], we observe no evidence that the response to the bacterial lysate impedes either type I or type II interferon signaling.

Whether specific molecular abnormalities can facilitate or impede response to therapy is a crucial issue in oncology (Tanner et al, 2006).

Development and widespread adoption of integrated PHRs will require understanding of and response to the factors that impede their adoption and potential contribution to the health system.